Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations.

Genes
Malwina Suszynska, Piotr Kozlowski

Abstract

Over the last two decades, numerous BARD1 mutations/pathogenic variants (PVs) have been found in patients with breast cancer (BC) and ovarian cancer (OC). However, their role in BC and OC susceptibility remains controversial, and strong evidence-based guidelines for carriers are not yet available. Herein, we present a comprehensive catalog of BARD1 PVs identified in large cumulative cohorts of ~48,700 BC and ~20,800 OC cases (retrieved from 123 studies examining the whole coding sequence of BARD1). Using these resources, we compared the frequency of BARD1 PVs in the cases and ~134,100 controls from the gnomAD database and estimated the effect of the BARD1 PVs on BC and OC risks. The analysis revealed that BARD1 is a BC moderate-risk gene (odds ratio (OR) = 2.90, 95% CIs:2.25-3.75, p < 0.0001) but not an OC risk gene (OR = 1.36, 95% CIs:0.87-2.11, p = 0.1733). In addition, the BARD1 mutational spectrum outlined in this study allowed us to determine recurrent PVs and evaluate the variant-specific risk for the most frequent PVs. In conclusion, these precise estimates improve the understanding of the role of BARD1 PVs in BC and OC predisposition and support the need for BARD1 diagnostic testing in BC patients.

References

Mar 30, 2001·The Journal of Biological Chemistry·R HashizumeT Ohta
Oct 11, 2003·Cancer Letters·Makoto IshitobiShinzaburo Noguchi
Dec 8, 2005·European Journal of Human Genetics : EJHG·Pia VahteristoHeli Nevanlinna
Jun 3, 2006·Genome Research·Matthew F RuddUNKNOWN GELCAPS Consortium
Sep 13, 2007·The Journal of Biological Chemistry·Marsha LauferRichard Baer
Dec 20, 2007·Cancer Research·Lin LiIrmgard Irminger-Finger
May 5, 2009·Nature Genetics·Mario CapassoJohn M Maris
Feb 24, 2011·Breast Cancer Research and Treatment·Magdalena RatajskaJanusz Limon
Aug 5, 2011·International Journal of Cancer. Journal International Du Cancer·Yong-Qiang ZhangIrmgard Irminger-Finger
Oct 19, 2011·Proceedings of the National Academy of Sciences of the United States of America·Tom WalshElizabeth M Swisher
Apr 26, 2014·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Holly LaDucaElizabeth Chao
Oct 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Johanna I KiiskiHeli Nevanlinna
Nov 28, 2014·Breast Cancer Research and Treatment·Jane E ChurpekOlufunmilayo I Olopade
Dec 3, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fergus J CouchPeter A Fasching
Dec 17, 2014·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Kara N MaxwellKatherine L Nathanson
Jan 27, 2015·Cancer Letters·Anna P SokolenkoEvgeny N Imyanitov
Jun 23, 2015·The FEBS Journal·Fatima AloraifiAdrian P Bracken
Aug 1, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Thangarajan RajkumarShirley Sundersingh
Sep 1, 2015·Journal of the National Cancer Institute·Susan J RamusSimon A Gayther
Oct 6, 2015·Molecular Genetics & Genomic Medicine·Yosuke HirotsuMasao Omata
Dec 19, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Lisa R SussweinWendy K Chung
Dec 22, 2015·Breast Cancer Research and Treatment·Tamar Yablonski-PeretzEitan Friedman
Jan 1, 2016·Gynecologic Oncology·Sarah S BernardsElizabeth M Swisher
Jan 1, 2016·JAMA Oncology·Barbara M NorquistMichael J Birrer
Jan 8, 2016·The International Journal of Biochemistry & Cell Biology·Irmgard Irminger-FingerMaxim Pilyugin
Jan 21, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ella R ThompsonIan G Campbell
Feb 5, 2016·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Brian H ShirtsColin C Pritchard
Mar 16, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nadine TungJudy E Garber

❮ Previous
Next ❯

Citations

Jul 4, 2021·Trends in Cell Biology·Min DengZhenkun Lou

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

MedCalc

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Biological Chemistry
Stefan SchüchnerBeric R Henderson
International Journal of Cancer. Journal International Du Cancer
Jian-Yu WuIrmgard Irminger-Finger
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Judith C SpornBarbara Jung
© 2021 Meta ULC. All rights reserved